EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent Uses of Lipid Nanoparticles, Cell-Penetrating and Bioactive Peptides for the Development of Brain-Targeted Nanomedicines against Neurodegenerative Disorders

Yu Wu, Angelina Angelova iD

Nanomaterials · 23.11.2023 · 13 (23) · 3004

DOI: 10.3390/nano13233004 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nanomaterials, online erschienen am 23.11.2023. Verfasst von Yu Wu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris-Saclay, CNRS, Institut Galien Paris-Saclay, 91400 Orsay, France. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 208 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The lack of effective treatments for neurodegenerative diseases (NDs) is an important current concern. Lipid nanoparticles can deliver innovative combinations of active molecules to target the various mechanisms of neurodegeneration. A significant challenge in delivering drugs to the brain for ND treatment is associated with the blood–brain barrier, which limits the effectiveness of conventional drug administration. Current strategies utilizing lipid nanoparticles and cell-penetrating peptides, characterized by various uptake mechanisms, have the potential to extend the residence time and bioavailability of encapsulated drugs. Additionally, bioactive molecules with neurotropic or neuroprotective properties can be delivered to potentially mediate the ND targeting pathways, e.g., neurotrophin deficiency, impaired lipid metabolism, mitochondrial dysfunction, endoplasmic reticulum stress, accumulation of misfolded proteins or peptide fragments, toxic protein aggregates, oxidative stress damage, and neuroinflammation. This review discusses recent advancements in lipid nanoparticles and CPPs in view of the integration of these two approaches into nanomedicine development and dual-targeted nanoparticulate systems for brain delivery in neurodegenerative disorders.

Schlagwörter

Stichwörter der Autor:innen

CPP-functionalized particlescell-penetrating peptide (CPP)cubosomeslipid nanoparticlesliquid crystalline nanocarriersnanomedicineneuroprotectionpituitary adenylate cyclase-activating polypeptide (PACAP)

Autor:innen und Institutionen

  • Université Paris-Saclay, CNRS, Institut Galien Paris-Saclay, 91400 Orsay, France.

ORCID-Profile: Angelina Angelova

Zitieren

APA

Wu, Y., & Angelova, A. (2023). Recent Uses of Lipid Nanoparticles, Cell-Penetrating and Bioactive Peptides for the Development of Brain-Targeted Nanomedicines against Neurodegenerative Disorders. Nanomaterials, 13(23), 3004. https://doi.org/10.3390/nano13233004

Vancouver

Wu Y, Angelova A. Recent Uses of Lipid Nanoparticles, Cell-Penetrating and Bioactive Peptides for the Development of Brain-Targeted Nanomedicines against Neurodegenerative Disorders. Nanomaterials. 2023;13(23):3004. doi:10.3390/nano13233004

BibTeX
@article{Wu2023,
  author = {Wu, Yu and Angelova, Angelina},
  title = {Recent Uses of Lipid Nanoparticles, Cell-Penetrating and Bioactive Peptides for the Development of Brain-Targeted Nanomedicines against Neurodegenerative Disorders},
  journal = {Nanomaterials},
  year = {2023},
  volume = {13},
  number = {23},
  pages = {3004},
  doi = {10.3390/nano13233004}
}
Kostenlos starten →